Life Science 2.0: reframing the life science sector for ‘the benefit on mankind’-Reference-Cited by-同舟云学术

Life Science 2.0: reframing the life science sector for ‘the benefit on mankind’

Published:2024-04-05 Issue:1 Volume:17 Page:
ISSN:1654-9716
Container-title:Global Health Action
language:en
Short-container-title:Global Health Action

Author:

Vallin Michaela¹^ORCID,Tomson Göran²^ORCID,Kampmann Beate³^ORCID,Engebretsen Eivind⁴^ORCID,Swartling Peterson Stefan⁵⁶,Wanyenze Rhoda K.⁶,Ottersen Ole Petter³⁷⁸^ORCID

Affiliation:

1. Chemical Biology Consortium Sweden, SciLifeLab, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden

2. Department of Learning, Informatics, Management, and Ethics, Karolinska Institutet, Stockholm, Sweden

3. Charité Centre of Global Health, Charité Universitätsmedizin, Berlin, Germany

4. Faculty of Medicine, University of Oslo, Oslo, Norway

5. Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden

6. College of Health Sciences, School of Public Health, Makerere University, Kampala, Uganda

7. Sustainable Health Unit and Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway

8. Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

Funder

no funding

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/16549716.2024.2330758

Reference32 articles.

1. COVID-19: the case for prosociality

2. Addressing Vaccine Inequity — Covid-19 Vaccines as a Global Public Good

3. Addressing production gaps for vaccines in African countries

4. Vaccine Justice and Bioethical Reflections of COVID-19 Immunization in Malaysia

5. COVID-19 Immunisation, Willingness to Be Vaccinated and Vaccination Strategies to Improve Vaccine Uptake in Australia